Johnson & Johnson’s Cerebras Systems CBRS Stock Holding History

Johnson & Johnson’s Portfolio CBRS Stock Details CBRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.8M	Buy	+53,586	New	+$12.6M	1.48%	9

Other funds holding CBRS

Eclipse Ventures Palo Alto, California $2.57B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Johnson & Johnson's CBRS Position: Q2 2026 in Review

Johnson & Johnson opened a new position in Cerebras Systems (CBRS) in Q2 2026: 53,586 shares worth $11.8M. The stake represents 1.48% of the portfolio and ranks #9 among its holdings.

271 funds tracked by Wall St. Rank hold CBRS as of Q2 2026.

Johnson & Johnson held 53,586 shares of Cerebras Systems worth $11.8M as of Q2 2026.
Cerebras Systems was a new Johnson & Johnson position in Q2 2026.
Cerebras Systems made up 1.48% of Johnson & Johnson's portfolio in Q2 2026, its #9 holding.
271 funds tracked by Wall St. Rank held Cerebras Systems as of Q2 2026.

Based on Johnson & Johnson's 13F filing for Q2 2026, filed 6 Aug 2026.